Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial (Q43821405)
Jump to navigation
Jump to search
scientific article published in December 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial |
scientific article published in December 2001 |
Statements
1 reference
Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial (English)
1 reference
H White
1 reference
Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators
1 reference
1 December 2001
1 reference
1 reference
Identifiers
1 reference